Collectively, this evidence highlights the role of SHP-1 as an oncogene in the tumor microenvironment, specifically in the immune cell population, suggesting that it may be a promising target to enlarge the repertoire of T cells sensitive to checkpoint blockade, finally leading to enhanced control of melanoma growth. The gene discussed is PTPN6; the disease is neoplasm.